Estimation of Absorbed Doses of Indigenously Produced “Direct-route” Lutetium-177-[ 177 Lu]Lu-DOTA-TATE PRRT in Normal Organs and Tumor Lesions in Patients of Metastatic Neuroendocrine Tumors: Comparison with No-Carrier-Added [ 177 Lu]Lu-DOTA-TATE and the Trend with Multiple Cycles
Cancer Biotherapy and Radiopharmaceuticals · 01.04.2022 · 37 (3) · 214-225
DOI: 10.1089/cbr.2021.0340 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Biotherapy and Radiopharmaceuticals, erschienen am 01.04.2022. Verfasst von Kamaldeep und 4 weiteren Autor:innen. Beteiligte Einrichtung: Radiation Medicine Centre, Bhabha Atomic Research Centre, Mumbai, India. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Organometallic Compounds. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Radiation Medicine Centre, Bhabha Atomic Research Centre, Mumbai, India.
- Homi Bhabha National Institute, Mumbai, India.
- Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, India.
ORCID-Profile: Sandip Basu, Sharmila Banerjee
Zitieren
APA
Kamaldeep, Loharkar, S., Das, T., Basu, S., & Banerjee, S. (2022). Estimation of Absorbed Doses of Indigenously Produced “Direct-route” Lutetium-177-[ 177 Lu]Lu-DOTA-TATE PRRT in Normal Organs and Tumor Lesions in Patients of Metastatic Neuroendocrine Tumors: Comparison with No-Carrier-Added [ 177 Lu]Lu-DOTA-TATE and the Trend with Multiple Cycles. Cancer Biotherapy and Radiopharmaceuticals, 37(3), 214-225. https://doi.org/10.1089/cbr.2021.0340
Vancouver
Kamaldeep, Loharkar S, Das T, Basu S, Banerjee S. Estimation of Absorbed Doses of Indigenously Produced “Direct-route” Lutetium-177-[ 177 Lu]Lu-DOTA-TATE PRRT in Normal Organs and Tumor Lesions in Patients of Metastatic Neuroendocrine Tumors: Comparison with No-Carrier-Added [ 177 Lu]Lu-DOTA-TATE and the Trend with Multiple Cycles. Cancer Biotherapy and Radiopharmaceuticals. 2022;37(3):214-225. doi:10.1089/cbr.2021.0340
BibTeX
@article{Kamaldeep2022,
author = {Kamaldeep and Loharkar, Sarvesh and Das, Tapas and Basu, Sandip and Banerjee, Sharmila},
title = {Estimation of Absorbed Doses of Indigenously Produced “Direct-route” Lutetium-177-[ 177 Lu]Lu-DOTA-TATE PRRT in Normal Organs and Tumor Lesions in Patients of Metastatic Neuroendocrine Tumors: Comparison with No-Carrier-Added [ 177 Lu]Lu-DOTA-TATE and the Trend with Multiple Cycles},
journal = {Cancer Biotherapy and Radiopharmaceuticals},
year = {2022},
volume = {37},
number = {3},
pages = {214--225},
doi = {10.1089/cbr.2021.0340}
}
EUVIMED